蛋白颗粒诱导动脉硬化ex vivo并损害血管细胞功能
Cédric H G Neutel1, Callan D Wesley2, Cindy van Loo3
1Laboratory of Physiopharmacology, University of Antwerp, Antwerp, Belgium. cedric.neutel@uantwerpen.be.
Communications biology
|October 2, 2024
概括
主要蛋白颗粒 (CPP1) 增加动脉硬性,并通过影响内皮和光滑肌肉细胞来损害血管功能. 在体内没有观察到这些效应,这表明CPP1可以诱导血管功能障碍.
科学领域:
- 生物化学 生物化学
- 生理学 生理学 生理学
- 血管生物学 血管生物学
背景情况:
- 蛋白颗粒 (CPP) 是内源性缓冲剂,可以防止子宫外矿化.
- CPPs存在于初级 (CPP1) 和二级 (CPP2) 形式.
- 以前的体外研究表明,CPP对血管光滑肌细胞 (VSMC) 有毒.
研究的目的:
- 为了研究CPP1和CPP2对血管功能的影响,ex vivo和in vivo.
- 确定CPPs影响血管特性的特定机制.
主要方法:
- 在对CPP1和CPP2的反应中对动脉硬性的ex vivo评估.
- 在体外分析内皮和VSMC功能.
- 测量动脉中的葡萄糖氨基含量.
- 在体内研究以评估血管效应.
主要成果:
- CPP1,但不是CPP2,显著增加了动脉硬度ex vivo.
- CPP1影响了内皮依赖的血管松和VSMC收缩.
- 随着CPP1暴露,观察到动脉葡萄糖氨基糖的积累增加.
- 在体内没有检测到任何显著的血管效应.
结论:
- 主要的蛋白颗粒 (CPP1) 诱导血管功能障碍.
- CPP1影响内皮和光滑肌肉细胞功能,导致动脉硬度增加.
- CPP1诱导的血管功能障碍的体内相关性需要进一步调查.
相关概念视频
Peripheral Artery Disease I: Introduction
3
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
3
Atherosclerosis I: Introduction
2
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2
Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Antihypertensive Drugs: Action of Calcium Channel Blockers
469
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
469
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K


